Time

Session

10:00  

Registration and Tea/Coffee

10:30

Welcome

Dr Bernard Croal, President, RCPath

10:35

Ministerial address

Dr Zubir Ahmed MP, Parliamentary Under-Secretary of State at the Department of Health and Social Care

10:45

Keynote address

Dr Rhydian Phillips, Director of Diagnostics & Transport, NHS England

11:00

Coffee break

11:20

The UK Life Sciences Sector Plan and pathology (presentation and Q&A)

Helen Dent, Chief Executive, BIVDA

11:35

Benefits of working in partnership with the RCPath – short talks from Corporate Member representatives with a Q&A

• Matt Johnson, Director of Access and Innovation, Roche Diagnostics

• Dr Amir Sharili, Precision Medicine Lead, Oncology and Rachel Dixon, Associate Director, Oncology Policy and Communication, MSD-UK

Please note – MSD-UK representatives will not be able to answer any questions on products or pipelines.

12:00

The National Cancer Plan for England – how can pathology and industry work together to support key priorities?

Ravi Chana, Executive Director, Diagnostics, ABHI

12:10

Reclaiming productivity in histopathology: evidence from the frontline (presentation and Q&A)

Dr Andrew Clarke, Consultant Histopathologist, Airedale Hospital and Director of PathoLogic Ltd

12:30

Lunch

13:30

Breakout discussion groups on following topics introduced by Professor Peter Johnston, RCPath Vice President for Workforce and Corporate Engagement

1. What are we trying to achieve with IT interoperability?
Dr Muhammad Aslam, Consultant Histopathologist and Clinical Director for North Wales Diagnostic and Specialist Clinical Services

2. Digital pathology and AI – identifying priority areas that achieve most gains for patients
Professor Louise Jones, Professor of breast pathology, Queen Mary University of London and Genomics England and Professor Clare Verrill, Professor in Cellular Pathology and AI with Nuffield Department of Surgical Sciences, University of Oxford, and Consultant in Cellular Pathology (Uropathology) at Oxford University Hospitals NHS Foundation Trust

3. Genomic cancer testing – advancing the service in partnership
Dr Guy Hannah, Consultant haematologist and haemato-pathologist, King’s College Hospital, and Dr David Moore, Consultant Thoracic and Molecular Pathologist, University College London Hospitals NHS Foundation Trust

4. How can industry and the College work together to support academic pathology/ translational research?
Professor Keith Hunter, Chair of RCPath Research Committee, and Professor Roland Fleck, Director of Centre for Ultrastructural Imaging, Kings College London

5. RCPath conference – involving industry in inaugural RCPath congress/ conference
Richard Smith, Head of Professional Practice, RCPath, and Conor Meany, Director of Business Development and Colm O’Grady, Commercial Director, Conference Partners International

6. Sharing experience and looking at ways to improve productivity in histopathology
Dr Andrew Clarke, Consultant Histopathologist, Airedale Hospital and Director of PathoLogic Ltd

1 hour facilitated discussions in separate rooms grouped by above topic areas.

14:30

Coffee and tea

14:50

Feedback from each discussion group chaired by Professor Peter Johnston, RCPath Vice President for Workforce and Engagement

Summary points from the discussions

Professor Sarah Coupland, RCPath Registrar

15:20

Summary of the day and next steps

Dr Bernard Croal, RCPath President

15:30

Close